These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7641247)
1. The effects of aspirin on the CNV in healthy individuals. Vein A; Voznesenskaya T; Danilov A Cephalalgia; 1995 Apr; 15(2):129-31; discussion 78. PubMed ID: 7641247 [TBL] [Abstract][Full Text] [Related]
2. [The effect of aspirin on the contingent negative wave in healthy subjects]. Veĭn AM; Voznesenskaia TG; Danilov AB Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):45-6. PubMed ID: 8533508 [TBL] [Abstract][Full Text] [Related]
3. Influence of aspirin on the contingent negative wave in healthy subjects. Vein AM; Voznesenskaya TG; Danilov AB Neurosci Behav Physiol; 1996; 26(5):489-91. PubMed ID: 9000223 [TBL] [Abstract][Full Text] [Related]
4. Effects of rizatriptan on the contingent negative variation in healthy women. Zank R; Strehl U; Larbig W; Kotchoubey B Cephalalgia; 2008 Sep; 28(9):922-32. PubMed ID: 18513259 [TBL] [Abstract][Full Text] [Related]
5. Lack of age-dependent development of the contingent negative variation (CNV) in migraine children? Bender S; Weisbrod M; Just U; Pfüller U; Parzer P; Resch F; Oelkers-Ax R Cephalalgia; 2002 Mar; 22(2):132-6. PubMed ID: 11972581 [TBL] [Abstract][Full Text] [Related]
6. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Kropp P; Gerber WD Cephalalgia; 1995 Apr; 15(2):123-8; discussion 78-9. PubMed ID: 7641246 [TBL] [Abstract][Full Text] [Related]
8. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Kropp P; Gerber WD Cephalalgia; 1993 Feb; 13(1):37-41. PubMed ID: 8448787 [TBL] [Abstract][Full Text] [Related]
10. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. de Tommaso M; Guido M; Sardaro M; Serpino C; Vecchio E; De Stefano G; Di Claudio T; Specchio LM; Livrea P Neurosci Lett; 2008 Sep; 442(2):81-5. PubMed ID: 18620023 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study. Siniatchkin M; Gerber WD; Vein A Funct Neurol; 1998; 13(1):47-56. PubMed ID: 9584874 [TBL] [Abstract][Full Text] [Related]
13. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study. Siniatchkin M; Andrasik F; Kropp P; Niederberger U; Strenge H; Averkina N; Lindner V; Stephani U; Gerber WD Cephalalgia; 2007 Sep; 27(9):1024-32. PubMed ID: 17680819 [TBL] [Abstract][Full Text] [Related]